BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3079809)

  • 21. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis.
    Gómez MI; Prince A
    Curr Opin Pharmacol; 2007 Jun; 7(3):244-51. PubMed ID: 17418640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.
    Coleman FT; Mueschenborn S; Meluleni G; Ray C; Carey VJ; Vargas SO; Cannon CL; Ausubel FM; Pier GB
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1949-54. PubMed ID: 12578988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic science for the chest physician: Pseudomonas aeruginosa and the cystic fibrosis airway.
    Williams HD; Davies JC
    Thorax; 2012 May; 67(5):465-7. PubMed ID: 22382597
    [No Abstract]   [Full Text] [Related]  

  • 24. Pseudomonas aeruginosa and the airways disease of cystic fibrosis.
    Hata JS; Fick RB
    Clin Chest Med; 1988 Dec; 9(4):679-89. PubMed ID: 3148384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas aeruginosa biofilms in a bronchoalveolar lavage.
    Pusztaszeri M; Aubert JD; Braunschweig R; Mihaescu A
    Diagn Cytopathol; 2009 Nov; 37(11):825. PubMed ID: 19191299
    [No Abstract]   [Full Text] [Related]  

  • 27. Pseudomonas infections in cystic fibrosis.
    George RH
    Arch Dis Child; 1987 May; 62(5):438-9. PubMed ID: 3111389
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical criteria of infection with Staphylococcus aureus and Pseudomonas aeruginosa].
    Brémont F
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S57-61. PubMed ID: 12910135
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiresistant pulmonary infection in cystic fibrosis--prevention is better than cure.
    Smyth A
    Lancet; 2005 Aug 6-12; 366(9484):433-5. PubMed ID: 16084235
    [No Abstract]   [Full Text] [Related]  

  • 30. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
    Gill JF; Deretic V; Chakrabarty AM
    Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating resistant Pseudomonas aeruginosa lung disease in young children with cystic fibrosis.
    Lim SZP; Fitzgerald DA
    Paediatr Respir Rev; 2018 Jun; 27():33-36. PubMed ID: 29033215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
    Evans TJ
    Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A murine model of chronic mucosal colonization by Pseudomonas aeruginosa.
    Pier GB; Meluleni G; Neuger E
    Infect Immun; 1992 Nov; 60(11):4768-76. PubMed ID: 1398987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors.
    Deretic V; Schurr MJ; Boucher JC; Martin DW
    J Bacteriol; 1994 May; 176(10):2773-80. PubMed ID: 8188579
    [No Abstract]   [Full Text] [Related]  

  • 35. Normal and Cystic Fibrosis Human Bronchial Epithelial Cells Infected with Pseudomonas aeruginosa Exhibit Distinct Gene Activation Patterns.
    Balloy V; Varet H; Dillies MA; Proux C; Jagla B; Coppée JY; Tabary O; Corvol H; Chignard M; Guillot L
    PLoS One; 2015; 10(10):e0140979. PubMed ID: 26485688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis.
    Langan KM; Kotsimbos T; Peleg AY
    Curr Opin Infect Dis; 2015 Dec; 28(6):547-56. PubMed ID: 26524327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review?
    Høiby N; Johansen HK
    J Hosp Infect; 2007 Apr; 65(4):374-5; author reply 375-6. PubMed ID: 17275952
    [No Abstract]   [Full Text] [Related]  

  • 38. [Colonization by pyocyanic bacillus and its treatment in cystic fibrosis].
    Lenoir G; de Montalembert M
    Rev Prat; 1990 Jun; 40(17):1559-65. PubMed ID: 2114037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-resistant Pseudomonas aeruginosa ST235 in cystic fibrosis.
    Lee AC; Jones AL
    Paediatr Respir Rev; 2018 Jun; 27():18-20. PubMed ID: 29914746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.
    Ulrich M; Beer I; Braitmaier P; Dierkes M; Kummer F; Krismer B; Schumacher U; Gräpler-Mainka U; Riethmüller J; Jensen PØ; Bjarnsholt T; Høiby N; Bellon G; Döring G
    Thorax; 2010 Nov; 65(11):978-84. PubMed ID: 20880875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.